Come up with a name for your new list and we'll add to it:
Biovation raised a round of funding on , . Investors include
Scottish Equity Partners.
Biovation focuses on proprietary technologies that eliminate immunogenicity in antibodies and other proteins in order to develop biotherapeutic drugs with a superior safety profile. Biovation's techno…